Drugs of Abuse Testing: Technologies and Global Markets
Report Scope:
The current report offers a detailed picture of the drug abuse testing market.
This report highlights the current and future market potential for drug abuse testing and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 and key market players.
This report discusses drug abuse testing and its various resources. It covers the overall drug abuse testing market, including drug testing products. The report further analyzes the market based on products, covering analyzers, consumables, laboratory services, and point-of-care devices. In addition, the report also analyzes various sample types in drug abuse testing that include blood, hair, sweat, oral, urine, and others. Furthermore, a complete regional analysis of the market is also presented in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (which includes Latin America, the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2022 through 2027. Estimated values are based on revenue generated by drug abuse testing companies as total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
The current report offers a detailed picture of the drug abuse testing market.
This report highlights the current and future market potential for drug abuse testing and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 and key market players.
This report discusses drug abuse testing and its various resources. It covers the overall drug abuse testing market, including drug testing products. The report further analyzes the market based on products, covering analyzers, consumables, laboratory services, and point-of-care devices. In addition, the report also analyzes various sample types in drug abuse testing that include blood, hair, sweat, oral, urine, and others. Furthermore, a complete regional analysis of the market is also presented in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (which includes Latin America, the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2022 through 2027. Estimated values are based on revenue generated by drug abuse testing companies as total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 23 data tables and 42 additional tables
- A comprehensive overview and an up-to-date analysis of the global markets for drugs of abuse (DOA) testing
- Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for DOA testing industry along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the marketplace
- Estimation of the actual market size and revenue forecast for the global drug abuse testing market in USD million values, and its corresponding market share analysis based on the product, sample type, drug type, testing type, end user, and region
- Technology assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and their influence in the market developments
- Statistical information covering drug abuse along with its trends as well as drug classes across the key geographic regions
- A comparative study and Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the market for drugs of abuse testing
- Review of the key patent grants and patent applications on drug abuse testing technologies
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Beckmann Coulter (Danaher Corp.), Roche Diagnostics, Quest Diagnostics Inc., LifeSign and Thermo Fisher Scientific Inc.
CHAPTER 1 INTRODUCTION
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 What's New in this Update?
1.4 Scope of Report
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
3.1 Overview
3.2 Testing Technologies
3.2.1 Urine Testing
3.2.2 Other Testing
3.3 Single Tests vs. Multiparameter Tests
3.4 DOA Screening
3.5 Porter's Five Forces Analysis
3.6 Future Outlook
3.7 Assessment of COVID-19's Impact on the Market
CHAPTER 4 MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Government Initiatives for Drug Abuse Testing
4.1.2 Increased Drug Trafficking
4.2 Market Restraints
4.2.1 Drug Testing at the Workplace Considered a Violation of Privacy Rights
4.3 Market Opportunities
4.3.1 Increasing Concern for Drink-Driving
CHAPTER 5 REGULATORY SCENARIO
5.1 North America
5.1.1 Canada
5.1.2 Mexico
5.1.3 The U.S.
5.1.4 State-level Marijuana Legalization
5.1.5 U.S. Department of Transportation
5.1.6 Drug Testing in the Military
5.1.7 Drug Testing for Welfare Recipients and Public Assistance
5.1.8 Drug Testing for Individuals Convicted of Drug Felonies
5.2 South America
5.2.1 Bolivia
5.2.2 Brazil
5.2.3 Colombia
5.2.4 Ecuador
5.2.5 Guyana
5.2.6 Paraguay
5.2.7 Peru
5.3 Central America and the Caribbean
5.3.1 Costa Rica
5.3.2 Cuba
5.3.3 El Salvador
5.3.4 Guatemala
5.3.5 Haiti
5.3.6 Jamaica
5.3.7 Nicaragua
5.3.8 Panama
5.3.9 Honduras
5.3.10 The Bahamas
5.3.11 The Netherlands Antilles
5.3.12 Trinidad and Tobago
5.4 Europe
5.4.1 Bosnia and Herzegovina
5.4.2 Denmark
5.4.3 France
5.4.4 Germany
5.4.5 Italy
5.4.6 Latvia
5.4.7 Norway
5.4.8 Romania
5.4.9 Sweden
5.4.10 Switzerland
5.4.11 The Netherlands
5.4.12 The U.K.
5.5 Asia-Pacific
5.5.1 Australia
5.5.2 Bangladesh
5.5.3 Bhutan
5.5.4 Cambodia
5.5.5 Hong Kong
5.5.6 India
5.5.7 Japan
5.5.8 Maldives
5.5.9 Myanmar
5.5.10 Nepal
5.5.11 New Zealand
5.5.12 Singapore
5.5.13 South Korea
5.5.14 Sri Lanka
5.5.15 Taiwan
5.5.16 Thailand
5.5.17 Vietnam
CHAPTER 6 GLOBAL DRUGS OF ABUSE TESTING MARKET BY DRUG TYPE
6.1 Overview
6.2 Alcohol
6.3 Amphetamine and Methamphetamine
6.4 Cannabis/Marijuana
6.5 Cocaine
6.6 Opioids
6.7 Others
CHAPTER 7 GLOBAL DRUGS OF ABUSE TESTING MARKET BY END USER
7.1 Overview
7.2 Drug Testing Laboratories
7.3 Hospitals
7.4 Workplaces
7.5 Others
7.5.1 U.S. Armed Forces Zero Tolerance Stance
CHAPTER 8 GLOBAL DRUGS OF ABUSE TESTING MARKET BY SAMPLE TYPE
8.1 Overview
8.2 Blood Testing
8.2.1 Market Size and Forecast
8.3 Hair Testing
8.3.1 Market Size and Forecast
8.4 Oral Fluid Testing
8.4.1 Market Size and Forecast
8.5 Sweat Testing
8.5.1 Market Size and Forecast
8.6 Urine Testing
8.6.1 Market Size and Forecast
8.7 Other Testing
8.7.1 Market Size and Forecast
CHAPTER 9 GLOBAL DRUGS OF ABUSE TESTING MARKET BY PRODUCT
9.1 Overview
9.2 Analyzers
9.2.1 Market Size and Forecast
9.3 Consumables
9.3.1 Market Size and Forecast
9.4 Laboratory Services
9.4.1 Market Size and Forecast
9.5 Point-of-Care/Rapid Testing Devices
9.5.1 Market Size and Forecast
CHAPTER 10 GLOBAL DRUGS OF ABUSE TESTING MARKET BY TESTING TYPE
10.1 Overview
10.2 Onsite Testing
10.2.1 Market Size and Forecast
10.3 Laboratory Testing
10.3.1 Market Size and Forecast
CHAPTER 11 MARKET BREAKDOWN BY REGION
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World (RoW)
11.5.1 RoW Market Size and Forecast
CHAPTER 12 PATENT ANALYSIS
CHAPTER 13 COMPETITIVE LANDSCAPE ANALYSIS
13.1 Overview
13.2 Company Ranking Analysis
13.3 Recent Developments and Initiatives
CHAPTER 14 COMPANY PROFILES
ABBOTT DIAGNOSTICS
ACON LABORATORIES INC.
AGILENT TECHNOLOGIES, INC.
ALFA SCIENTIFIC DESIGNS, INC.
AMERICAN BIO MEDICA
BIO-RAD LABORATORIES, INC.
CONFIRM BIOSCIENCES
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
IDENTA CORP.
LIFESIGN LLC
MAVAND SOLUTIONS
MEDTOX DIAGNOSTICS
MOSSMAN ASSOCIATES
MP BIOMEDICALS
NANO-DITECH CORP.
ONE STEP DETECT ASSOCIATES
ORASURE
ORTHO-CLINICAL DIAGNOSTICS
PRECHEK BIO
PRINCETON BIOMEDITECH
PSYCHEMEDICS
QUEST DIAGNOSTICS INC.
RANDOX LABORATORIES LTD.
REDWOOD TOXICOLOGY LABORATORY, INC.
SHIMADZU CORP.
SIEMENS HEALTHINEERS
THERMO FISHER SCIENTIFIC, INC.
UCP BIOSCIENCES
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 What's New in this Update?
1.4 Scope of Report
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
3.1 Overview
3.2 Testing Technologies
3.2.1 Urine Testing
3.2.2 Other Testing
3.3 Single Tests vs. Multiparameter Tests
3.4 DOA Screening
3.5 Porter's Five Forces Analysis
3.6 Future Outlook
3.7 Assessment of COVID-19's Impact on the Market
CHAPTER 4 MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Government Initiatives for Drug Abuse Testing
4.1.2 Increased Drug Trafficking
4.2 Market Restraints
4.2.1 Drug Testing at the Workplace Considered a Violation of Privacy Rights
4.3 Market Opportunities
4.3.1 Increasing Concern for Drink-Driving
CHAPTER 5 REGULATORY SCENARIO
5.1 North America
5.1.1 Canada
5.1.2 Mexico
5.1.3 The U.S.
5.1.4 State-level Marijuana Legalization
5.1.5 U.S. Department of Transportation
5.1.6 Drug Testing in the Military
5.1.7 Drug Testing for Welfare Recipients and Public Assistance
5.1.8 Drug Testing for Individuals Convicted of Drug Felonies
5.2 South America
5.2.1 Bolivia
5.2.2 Brazil
5.2.3 Colombia
5.2.4 Ecuador
5.2.5 Guyana
5.2.6 Paraguay
5.2.7 Peru
5.3 Central America and the Caribbean
5.3.1 Costa Rica
5.3.2 Cuba
5.3.3 El Salvador
5.3.4 Guatemala
5.3.5 Haiti
5.3.6 Jamaica
5.3.7 Nicaragua
5.3.8 Panama
5.3.9 Honduras
5.3.10 The Bahamas
5.3.11 The Netherlands Antilles
5.3.12 Trinidad and Tobago
5.4 Europe
5.4.1 Bosnia and Herzegovina
5.4.2 Denmark
5.4.3 France
5.4.4 Germany
5.4.5 Italy
5.4.6 Latvia
5.4.7 Norway
5.4.8 Romania
5.4.9 Sweden
5.4.10 Switzerland
5.4.11 The Netherlands
5.4.12 The U.K.
5.5 Asia-Pacific
5.5.1 Australia
5.5.2 Bangladesh
5.5.3 Bhutan
5.5.4 Cambodia
5.5.5 Hong Kong
5.5.6 India
5.5.7 Japan
5.5.8 Maldives
5.5.9 Myanmar
5.5.10 Nepal
5.5.11 New Zealand
5.5.12 Singapore
5.5.13 South Korea
5.5.14 Sri Lanka
5.5.15 Taiwan
5.5.16 Thailand
5.5.17 Vietnam
CHAPTER 6 GLOBAL DRUGS OF ABUSE TESTING MARKET BY DRUG TYPE
6.1 Overview
6.2 Alcohol
6.3 Amphetamine and Methamphetamine
6.4 Cannabis/Marijuana
6.5 Cocaine
6.6 Opioids
6.7 Others
CHAPTER 7 GLOBAL DRUGS OF ABUSE TESTING MARKET BY END USER
7.1 Overview
7.2 Drug Testing Laboratories
7.3 Hospitals
7.4 Workplaces
7.5 Others
7.5.1 U.S. Armed Forces Zero Tolerance Stance
CHAPTER 8 GLOBAL DRUGS OF ABUSE TESTING MARKET BY SAMPLE TYPE
8.1 Overview
8.2 Blood Testing
8.2.1 Market Size and Forecast
8.3 Hair Testing
8.3.1 Market Size and Forecast
8.4 Oral Fluid Testing
8.4.1 Market Size and Forecast
8.5 Sweat Testing
8.5.1 Market Size and Forecast
8.6 Urine Testing
8.6.1 Market Size and Forecast
8.7 Other Testing
8.7.1 Market Size and Forecast
CHAPTER 9 GLOBAL DRUGS OF ABUSE TESTING MARKET BY PRODUCT
9.1 Overview
9.2 Analyzers
9.2.1 Market Size and Forecast
9.3 Consumables
9.3.1 Market Size and Forecast
9.4 Laboratory Services
9.4.1 Market Size and Forecast
9.5 Point-of-Care/Rapid Testing Devices
9.5.1 Market Size and Forecast
CHAPTER 10 GLOBAL DRUGS OF ABUSE TESTING MARKET BY TESTING TYPE
10.1 Overview
10.2 Onsite Testing
10.2.1 Market Size and Forecast
10.3 Laboratory Testing
10.3.1 Market Size and Forecast
CHAPTER 11 MARKET BREAKDOWN BY REGION
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World (RoW)
11.5.1 RoW Market Size and Forecast
CHAPTER 12 PATENT ANALYSIS
CHAPTER 13 COMPETITIVE LANDSCAPE ANALYSIS
13.1 Overview
13.2 Company Ranking Analysis
13.3 Recent Developments and Initiatives
CHAPTER 14 COMPANY PROFILES
ABBOTT DIAGNOSTICS
ACON LABORATORIES INC.
AGILENT TECHNOLOGIES, INC.
ALFA SCIENTIFIC DESIGNS, INC.
AMERICAN BIO MEDICA
BIO-RAD LABORATORIES, INC.
CONFIRM BIOSCIENCES
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
IDENTA CORP.
LIFESIGN LLC
MAVAND SOLUTIONS
MEDTOX DIAGNOSTICS
MOSSMAN ASSOCIATES
MP BIOMEDICALS
NANO-DITECH CORP.
ONE STEP DETECT ASSOCIATES
ORASURE
ORTHO-CLINICAL DIAGNOSTICS
PRECHEK BIO
PRINCETON BIOMEDITECH
PSYCHEMEDICS
QUEST DIAGNOSTICS INC.
RANDOX LABORATORIES LTD.
REDWOOD TOXICOLOGY LABORATORY, INC.
SHIMADZU CORP.
SIEMENS HEALTHINEERS
THERMO FISHER SCIENTIFIC, INC.
UCP BIOSCIENCES
LIST OF TABLES
Summary Table: Global Market for Drugs of Abuse Testing, by Region, Through 2027
Table 1: Cutoff Concentrations for Initial and Confirmatory Drug Tests in Urine
Table 2: Deaths from Tobacco, Alcohol and Drugs, Across Countries, 2019
Table 3: Commonly Abused Drugs
Table 4: Prevalence of Drug Use in General, Population Across Region, 2020
Table 5: Global Drug Seizure, by Drug Type, 2020
Table 6: U.S. Drug Testing Legislation, by State, 2017
Table 7: European Drug Testing Legislation, by Country
Table 8: Global Market for Drugs of Abuse Testing, by Sample Type, Through 2027
Table 9: Global Market for Blood Testing, by Region, Through 2027
Table 10: Global Market for Hair Testing, by Region, Through 2027
Table 11: Global Market for Oral Fluid Testing, by Region, Through 2027
Table 12: Global Market for Sweat Testing, by Region, Through 2027
Table 13: Cutoff Concentrations for Initial and Confirmatory Drug Tests in Urine
Table 14: Global Market for Urine Testing, by Region, Through 2027
Table 15: Advantages and Disadvantages of Various Matrices for Drug Abuse Testing
Table 16: Global Market for Other Testing Samples, by Region, Through 2027
Table 17: Global Market for Drugs of Abuse Testing, by Product, Through 2027
Table 18: Global Market for Analyzers, by Region, Through 2027
Table 19: Global Market for Consumables, by Region, Through 2027
Table 20: Global Market for Laboratory Services, by Region, Through 2027
Table 21: Advantages and Disadvantages of Point-of-Care Testing
Table 22: Global Market for Point-of-Care/Rapid Testing, by Region, Through 2027
Table 23: Global Market for Drugs of Abuse Testing, by Testing Type, Through 2027
Table 24: Major Advantages and Disadvantages of Onsite Testing
Table 25: Global Market for Onsite Testing for Drugs of Abuse, by Region, Through 2027
Table 26: Comparison of Federal Workplace Drug Testing and Clinical Drug Testing
Table 27: Global Market for Laboratory Testing for Drugs of Abuse, by Region, Through 2027
Table 28: Global Market for Drugs of Abuse Testing, by Region, Through 2027
Table 29: North American Market for Drugs of Abuse Testing, by Country, Through 2027
Table 30: European Market for Drugs of Abuse Testing, by Country, Through 2027
Table 31: Asia-Pacific Market for Drugs of Abuse Testing, by Country, Through 2027
Table 32: Patents on Drug Abuse Testing Technologies, 2020-2023
Table 33: Company Ranking for Drugs of Abuse Testing
Table 34: Recent Developments and Initiatives in the Drugs of Abuse Testing Industry, 2020-2022
Table 35: Abbott Diagnostics: Financials, 2019-2021
Table 36: Abbott Laboratories: DOA Testing Product Portfolio
Table 37: Acon Laboratories Inc.: DOA Testing Product Portfolio
Table 38: Agilent Technologies, Inc.: DOA Testing Product Portfolio
Table 39: Alfa Scientific Designs: DOA Testing Product Portfolio
Table 40: ABMC: DOA Testing Product Portfolio
Table 41: Bio-Rad Laboratories: DOA Testing Product Portfolio
Table 42: Confirm Biosciences Inc.: DOA Testing Product Portfolio
Table 43: Danaher Corp.: DOA Testing Product Portfolio
Table 44: F. Hoffmann-La Roche Ltd.: DOA Testing Product Portfolio
Table 45: IDenta Corp.: DOA Testing Product Portfolio
Table 46: LifeSign: DOA Testing Product Portfolio
Table 47: MAVAND Solutions GmbH: DOA Testing Product Portfolio
Table 48: Medtox Diagnostics: DOA Testing Product Portfolio
Table 49: Mossman Associates: DOA Testing Product Portfolio
Table 50: MP Biomedicals: DOA Testing Product Portfolio
Table 51: Nano-Ditech Corp: DOA Testing Product Portfolio
Table 52: One Step Detect Associates: DOA Testing Product Portfolio
Table 53: OraSure: DOA Testing Product Portfolio
Table 54: Ortho-Clinical Diagnostics Inc.: DOA Testing Product Portfolio
Table 55: PreChek Bio: DOA Testing Product Portfolio
Table 56: Princeton BioMeditech: DOA Testing Product Portfolio
Table 57: Psychemedics: DOA Testing Product Portfolio
Table 58: Quest Diagnostics Inc.: DOA Testing Product Portfolio
Table 59: Randox Laboratories Ltd.: DOA Testing Product Portfolio
Table 60: Redwood Toxicology Laboratory, Inc.: DOA Testing Product Portfolio
Table 61: Shimadzu Corp: DOA Testing Product Portfolio
Table 62: Siemens Healthcare: DOA Testing Product Portfolio
Table 63: Thermo Fisher Scientific, Inc.: DOA Testing Product Portfolio
Table 64: UCP Biosciences: DOA Testing Product Portfolio
Summary Table: Global Market for Drugs of Abuse Testing, by Region, Through 2027
Table 1: Cutoff Concentrations for Initial and Confirmatory Drug Tests in Urine
Table 2: Deaths from Tobacco, Alcohol and Drugs, Across Countries, 2019
Table 3: Commonly Abused Drugs
Table 4: Prevalence of Drug Use in General, Population Across Region, 2020
Table 5: Global Drug Seizure, by Drug Type, 2020
Table 6: U.S. Drug Testing Legislation, by State, 2017
Table 7: European Drug Testing Legislation, by Country
Table 8: Global Market for Drugs of Abuse Testing, by Sample Type, Through 2027
Table 9: Global Market for Blood Testing, by Region, Through 2027
Table 10: Global Market for Hair Testing, by Region, Through 2027
Table 11: Global Market for Oral Fluid Testing, by Region, Through 2027
Table 12: Global Market for Sweat Testing, by Region, Through 2027
Table 13: Cutoff Concentrations for Initial and Confirmatory Drug Tests in Urine
Table 14: Global Market for Urine Testing, by Region, Through 2027
Table 15: Advantages and Disadvantages of Various Matrices for Drug Abuse Testing
Table 16: Global Market for Other Testing Samples, by Region, Through 2027
Table 17: Global Market for Drugs of Abuse Testing, by Product, Through 2027
Table 18: Global Market for Analyzers, by Region, Through 2027
Table 19: Global Market for Consumables, by Region, Through 2027
Table 20: Global Market for Laboratory Services, by Region, Through 2027
Table 21: Advantages and Disadvantages of Point-of-Care Testing
Table 22: Global Market for Point-of-Care/Rapid Testing, by Region, Through 2027
Table 23: Global Market for Drugs of Abuse Testing, by Testing Type, Through 2027
Table 24: Major Advantages and Disadvantages of Onsite Testing
Table 25: Global Market for Onsite Testing for Drugs of Abuse, by Region, Through 2027
Table 26: Comparison of Federal Workplace Drug Testing and Clinical Drug Testing
Table 27: Global Market for Laboratory Testing for Drugs of Abuse, by Region, Through 2027
Table 28: Global Market for Drugs of Abuse Testing, by Region, Through 2027
Table 29: North American Market for Drugs of Abuse Testing, by Country, Through 2027
Table 30: European Market for Drugs of Abuse Testing, by Country, Through 2027
Table 31: Asia-Pacific Market for Drugs of Abuse Testing, by Country, Through 2027
Table 32: Patents on Drug Abuse Testing Technologies, 2020-2023
Table 33: Company Ranking for Drugs of Abuse Testing
Table 34: Recent Developments and Initiatives in the Drugs of Abuse Testing Industry, 2020-2022
Table 35: Abbott Diagnostics: Financials, 2019-2021
Table 36: Abbott Laboratories: DOA Testing Product Portfolio
Table 37: Acon Laboratories Inc.: DOA Testing Product Portfolio
Table 38: Agilent Technologies, Inc.: DOA Testing Product Portfolio
Table 39: Alfa Scientific Designs: DOA Testing Product Portfolio
Table 40: ABMC: DOA Testing Product Portfolio
Table 41: Bio-Rad Laboratories: DOA Testing Product Portfolio
Table 42: Confirm Biosciences Inc.: DOA Testing Product Portfolio
Table 43: Danaher Corp.: DOA Testing Product Portfolio
Table 44: F. Hoffmann-La Roche Ltd.: DOA Testing Product Portfolio
Table 45: IDenta Corp.: DOA Testing Product Portfolio
Table 46: LifeSign: DOA Testing Product Portfolio
Table 47: MAVAND Solutions GmbH: DOA Testing Product Portfolio
Table 48: Medtox Diagnostics: DOA Testing Product Portfolio
Table 49: Mossman Associates: DOA Testing Product Portfolio
Table 50: MP Biomedicals: DOA Testing Product Portfolio
Table 51: Nano-Ditech Corp: DOA Testing Product Portfolio
Table 52: One Step Detect Associates: DOA Testing Product Portfolio
Table 53: OraSure: DOA Testing Product Portfolio
Table 54: Ortho-Clinical Diagnostics Inc.: DOA Testing Product Portfolio
Table 55: PreChek Bio: DOA Testing Product Portfolio
Table 56: Princeton BioMeditech: DOA Testing Product Portfolio
Table 57: Psychemedics: DOA Testing Product Portfolio
Table 58: Quest Diagnostics Inc.: DOA Testing Product Portfolio
Table 59: Randox Laboratories Ltd.: DOA Testing Product Portfolio
Table 60: Redwood Toxicology Laboratory, Inc.: DOA Testing Product Portfolio
Table 61: Shimadzu Corp: DOA Testing Product Portfolio
Table 62: Siemens Healthcare: DOA Testing Product Portfolio
Table 63: Thermo Fisher Scientific, Inc.: DOA Testing Product Portfolio
Table 64: UCP Biosciences: DOA Testing Product Portfolio
LIST OF FIGURES
Summary Figure: Global Market Shares of Drugs of Abuse Testing, by Region, 2021
Figure 1: Annual Self-reported Alcohol-impaired Driving Episodes Among U.S. Adults, 2010–2020
Figure 2: Legal Adult-Use Cannabis Sales Worldwide, 2020–2025*
Figure 3: Global Market Shares of Drugs of Abuse Testing, by Sample Type, 2021
Figure 4: Global Market Shares of Drugs of Abuse Testing, by Product, 2021
Figure 5: Global Market Shares of Drugs of Abuse Testing, by Testing Type, 2021
Figure 6: Global Market Shares of Drugs of Abuse Testing, by Region, 2021
Figure 7: North American Market Shares of Drugs of Abuse Testing, by Country, 2021
Figure 8: Drug Overdose Death Shares in the United States, by Type of Drugs, 2021
Figure 9: U.S. Market for Drugs of Abuse Testing, 2021-2027
Figure 10: Canadian Market for Drugs of Abuse Testing, 2021-2027
Figure 11: German Market for Drugs of Abuse Testing, 2021-2027
Figure 12: U.K. Market for Drugs of Abuse Testing, 2021-2027
Figure 13: French Market for Drugs of Abuse Testing, 2021-2027
Figure 14: Rest of the European Market for Drugs of Abuse Testing, 2021-2027
Figure 15: Chinese Market for Drugs of Abuse Testing, 2021-2027
Figure 16: Japanese Market for Drugs of Abuse Testing, 2021-2027
Figure 17: Indian Market for Drugs of Abuse Testing, 2021-2027
Figure 18: Rest of Asia-Pacific Market for Drugs of Abuse Testing, 2021-2027
Figure 19: Rest of the World Market for Drugs of Abuse Testing, 2021-2027
Figure 20: Patent Shares on Drug Abuse Testing Technologies, by Geography, 2021
Figure 21: Patents on Drug Abuse Testing Technologies, by Company
Summary Figure: Global Market Shares of Drugs of Abuse Testing, by Region, 2021
Figure 1: Annual Self-reported Alcohol-impaired Driving Episodes Among U.S. Adults, 2010–2020
Figure 2: Legal Adult-Use Cannabis Sales Worldwide, 2020–2025*
Figure 3: Global Market Shares of Drugs of Abuse Testing, by Sample Type, 2021
Figure 4: Global Market Shares of Drugs of Abuse Testing, by Product, 2021
Figure 5: Global Market Shares of Drugs of Abuse Testing, by Testing Type, 2021
Figure 6: Global Market Shares of Drugs of Abuse Testing, by Region, 2021
Figure 7: North American Market Shares of Drugs of Abuse Testing, by Country, 2021
Figure 8: Drug Overdose Death Shares in the United States, by Type of Drugs, 2021
Figure 9: U.S. Market for Drugs of Abuse Testing, 2021-2027
Figure 10: Canadian Market for Drugs of Abuse Testing, 2021-2027
Figure 11: German Market for Drugs of Abuse Testing, 2021-2027
Figure 12: U.K. Market for Drugs of Abuse Testing, 2021-2027
Figure 13: French Market for Drugs of Abuse Testing, 2021-2027
Figure 14: Rest of the European Market for Drugs of Abuse Testing, 2021-2027
Figure 15: Chinese Market for Drugs of Abuse Testing, 2021-2027
Figure 16: Japanese Market for Drugs of Abuse Testing, 2021-2027
Figure 17: Indian Market for Drugs of Abuse Testing, 2021-2027
Figure 18: Rest of Asia-Pacific Market for Drugs of Abuse Testing, 2021-2027
Figure 19: Rest of the World Market for Drugs of Abuse Testing, 2021-2027
Figure 20: Patent Shares on Drug Abuse Testing Technologies, by Geography, 2021
Figure 21: Patents on Drug Abuse Testing Technologies, by Company
